Hepatic encephalopathy: risk identification and prophylaxis approaches

Area of Science:

• Hepatology and Neurology
• Gastroenterology
• Clinical Medicine

Background:

• Hepatic encephalopathy (HE) is a severe neurological complication of cirrhosis.
• It significantly impairs cognitive function and quality of life.
• HE poses a substantial burden on healthcare systems due to frequent hospitalizations.

Purpose of the Study:

• To review current prophylactic strategies for preventing hepatic encephalopathy in cirrhosis patients.
• To evaluate established treatments, emerging therapies, and predictive tools for HE risk stratification.
• To discuss future directions in personalized HE management.

Main Methods:

• Comprehensive literature review of prophylactic strategies for HE.
• Analysis of established treatments (lactulose, rifaximin).
• Evaluation of novel therapeutic approaches (L-ornithine L-aspartate, albumin, antioxidants) and predictive models (AMMON-OHE score, clinical-genetic assessments).

Main Results:

• Lactulose and rifaximin are effective in reducing ammonia and preventing HE recurrence.
• Emerging therapies show promise in addressing inflammation and gut dysbiosis.
• Predictive models enable tailored preventive interventions for high-risk individuals.

Conclusions:

• Advancements in HE prophylaxis are crucial for reducing overt HE incidence and hospital admissions.
• Personalized medicine, targeting specific pathways, represents the future of HE management.
• Continued research is vital to refine strategies and improve patient prognosis and quality of life.